- Home
- Publications
- Publication Search
- Publication Details
Title
Quadruple negative breast cancer
Authors
Keywords
-
Journal
Breast Cancer
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-15
DOI
10.1007/s12282-020-01047-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development and validation of nomograms integrating immune-related genomic signatures with clinicopathologic features to improve prognosis and predictive value of triple-negative breast cancer: A gene expression-based retrospective study
- (2019) Kang Wang et al. Cancer Medicine
- Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
- (2019) Ana C. Garrido-Castro et al. Cancer Discovery
- Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides
- (2019) Anabel Sorolla et al. Nanomedicine-Nanotechnology Biology and Medicine
- EN1 is a transcriptional dependency in triple-negative breast cancer associated with brain metastasis
- (2019) Guillermo Peluffo et al. CANCER RESEARCH
- Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer
- (2018) Yu Jin Kim et al. CANCER BIOLOGY & THERAPY
- Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer
- (2018) Tiffany A. Traina et al. JOURNAL OF CLINICAL ONCOLOGY
- AR negative triple negative or “quadruple negative” breast cancers in African American women have an enriched basal and immune signature
- (2018) Melissa Davis et al. PLoS One
- Differential Claudin 3 and EGFR Expression Predicts BRCA1 Mutation in Triple-Negative Breast Cancer
- (2018) Sabine Danzinger et al. CANCER INVESTIGATION
- Serum levels of circulating miRNA-21, miRNA-10b and miRNA-200c in triple-negative breast cancer patients
- (2018) Sebastian Niedźwiecki et al. Ginekologia Polska
- Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression
- (2018) Ulises Daniel Orlando et al. BIOCHEMICAL PHARMACOLOGY
- Quadruple Negative Breast Cancers (QNBC) Demonstrate Subtype Consistency among Primary and Recurrent or Metastatic Breast Cancer
- (2018) Anusha Angajala et al. Translational Oncology
- Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance
- (2017) Meng-Chi Yen et al. ONCOLOGY REPORTS
- Triple-negative breast cancer and the potential for targeted therapy
- (2017) Jing-Ru Jhan et al. PHARMACOGENOMICS
- Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer
- (2017) Zhihao Zeng et al. YONSEI MEDICAL JOURNAL
- The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC)
- (2017) Nobumoto Tomioka et al. Breast Cancer
- EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
- (2017) Chao-Qun Wang et al. Scientific Reports
- Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer
- (2016) Andrew J. Robles et al. BREAST CANCER RESEARCH AND TREATMENT
- Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation
- (2016) Wenwen Zhang et al. CELL CYCLE
- Targeting the androgen receptor in triple-negative breast cancer
- (2016) Ayca Gucalp et al. CURRENT PROBLEMS IN CANCER
- MicroRNA in pancreatic cancer
- (2016) Keiichi Yonemori et al. JOURNAL OF HUMAN GENETICS
- miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
- (2015) Andrea Mathe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo
- (2015) V. N. Barton et al. MOLECULAR CANCER THERAPEUTICS
- Circulating microRNA-based screening tool for breast cancer
- (2015) Pierre Frères et al. Oncotarget
- Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis
- (2015) Li Zhang et al. Biomed Research International
- New Strategies for Triple-Negative Breast Cancer--Deciphering the Heterogeneity
- (2014) I. A. Mayer et al. CLINICAL CANCER RESEARCH
- SKP2 Overexpression Is Associated With Increased Serine 10 Phosphorylation of p27 (pSer10p27) in Triple-Negative Breast Cancer
- (2014) Katerina D. Fagan-Solis et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma
- (2014) Rika Fujii et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer
- (2014) Mao Ouyang et al. PLoS One
- Expression of Long-chain Fatty Acyl-CoA Synthetase 4 in Breast and Prostate Cancers Is Associated with Sex Steroid Hormone Receptor Negativity
- (2014) Marie E. Monaco et al. Translational Oncology
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
- (2013) A. Gucalp et al. CLINICAL CANCER RESEARCH
- Deregulated Serum Concentrations of Circulating Cell-Free MicroRNAs miR-17, miR-34a, miR-155, and miR-373 in Human Breast Cancer Development and Progression
- (2013) C. Eichelser et al. CLINICAL CHEMISTRY
- Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function
- (2013) A S Beltran et al. ONCOGENE
- Long Chain Fatty Acyl-CoA Synthetase 4 Is a Biomarker for and Mediator of Hormone Resistance in Human Breast Cancer
- (2013) Xinyu Wu et al. PLoS One
- Apocrine Carcinoma as Triple-negative Breast Cancer: Novel Definition of Apocrine-type Carcinoma as Estrogen/Progesterone Receptor-negative and Androgen Receptor-positive Invasive Ductal Carcinoma
- (2012) Y. Tsutsumi JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
- (2011) Laura C Collins et al. MODERN PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started